Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, the stomach gives a slightly faster absorption rate, but the thigh is equally valid and the difference is clinically small. Mounjaro's licensed injection sites are the abdomen, thigh, and upper arm — rotating between them each week matters more than picking one perfect spot. That said, the stomach and thigh each have practical trade-offs worth knowing before you decide on a routine. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses every patient individually and can advise on injection technique as part of your ongoing care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Subcutaneous injections into the abdomen generally produce a slightly quicker absorption rate than those into the thigh. This is consistent with what's observed across most subcutaneous medicines: the abdomen has a richer subcutaneous blood supply in most adults, which helps the drug reach circulation a little sooner. For Mounjaro (tirzepatide), the practical difference is small. You are not going to notice a meaningful change in how the medicine feels week to week based on site selection alone.
What does matter is that you stay in the subcutaneous layer. Injecting too shallowly (into skin only) or too deeply (into muscle) affects absorption more than the site itself. The thigh (specifically the outer, middle third) has a consistent fat layer in most people, which makes it a reliable and predictable target. The technique for injecting into the thigh is straightforward, and many patients find it the easiest site to manage alone.
If you want to understand the stomach site in more detail, the map of Mounjaro abdominal injection sites covers exactly where in the abdomen to aim and which areas to avoid.
Injection-site reactions (redness, mild swelling, itching, or small lumps under the skin) are among the most commonly reported local side effects with Mounjaro. The site you choose can influence these, but rotation is what prevents them building up in any one area.
If you inject the same spot repeatedly, lipohypertrophy (a hardening of the fatty tissue) can develop over time. The medicine absorbs unpredictably from hardened tissue, so it's worth taking rotation seriously. A practical system is to divide the abdomen into four quadrants and work around them, or alternate the abdomen one week and the thigh the next.
Some patients find the thigh produces less visible redness after injections, possibly because that skin area is less reactive for them personally. Others notice the opposite. There is no universal rule, your own skin's response is the best guide after a few weeks. A guide to choosing the right spot on your stomach for Mounjaro explains the avoidance zones in the abdomen (navel, scarred tissue, waistband areas) that apply regardless of site preference.
Report any persistent lumps, pain, or skin changes to your prescriber rather than continuing to inject into the affected area.
Yes, noticeably. The KwikPen that arrives in your plain DPD delivery comes with a needle already attached for the first dose, but needle length and gauge affect comfort at each site. The thigh tends to have a thinner subcutaneous layer than the abdomen in leaner individuals, so a shorter, finer needle can reduce discomfort there. Conversely, patients with more subcutaneous tissue may find a slightly longer needle reaches the right layer more reliably in the thigh.
Standard guidance is to use a fresh needle for every injection, not just for hygiene, but because a reused needle tip blunts and increases discomfort. Replacement needles compatible with the KwikPen are available if you need to restock between pens. Injecting at a 90-degree angle is the standard approach for most body types; very lean patients may be advised by their prescriber to use a skin fold or a slight angle instead.
Before each injection, cleaning the skin with an alcohol swab and letting it dry for 10 seconds reduces the sting on injection. For more on the full abdominal technique, the step-by-step guide to stomach injections for tirzepatide is worth reading alongside this page.
Keep changing. The SmPC and NHS guidance are unambiguous on this: rotate injection sites every week. Within each site, vary the exact spot too, several centimetres from the previous week's injection in the same area. This simple habit is the single most effective thing you can do to protect your skin over a course of treatment that may last many months.
A common practical approach is a weekly rotation pattern: abdomen left, thigh right, abdomen right, upper arm left, and so on. Write it in a note on your phone or mark a body diagram if that helps you track it. Consistency in rotation does more for your experience of injections than any debate about stomach versus thigh.
If you are curious about how specific abdominal zones compare for Mounjaro, or want a broader overview of how the Mounjaro injection works from pen to body, both pages go into more depth on those questions. For context on the treatment itself, the Mounjaro overview covers the medicine's licensed use, clinical evidence, and what to expect. Injecting technique is one small part of getting the most from treatment, and it's the kind of question our prescribers are happy to discuss at any point. Speak to our prescribers if you're considering starting or have questions mid-treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.